Effects of Adolescent Synaptic Pruning (SPA PET)
研究概览
详细说明
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、美国、15213
- Laboratory of Neurocognitive Development
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Males or females between 18-26 years of age, AND currently enrolled in the Parent Project (R01MH067924)
Exclusion Criteria: (these exclusion criteria are outlined in the Parent Project)
- Head injury with loss of consciousness over an hour.
- A vision problem or eye movement problem (such as lazy eye, double vision, blurred vision, or color blindness).
- A learning disability and/or ever had an Individualized Education Plan (IEP) in school.
- Significant neurological or metabolic illness: Epilepsy, Meningitis, Encephalitis, Diabetes, Huntington's disease.
- Diagnosed with a psychiatric disorder.
- Participants with, or with a first degree relative, having a DSM IV Axis l psychiatricdisorder.
- Metal implants or ferromagnetic objects contained within the body which may interfere with the MRI scan (but not limited to, those with a pacemaker, presence of metallic fragments near the eyes or spinal cord, or cochlear implant.) Dental fillings do not present a risk for MRI. If there is a possibility of metal being present in the participant's body, the participant will be excluded from the study.
- Weight more than 250 pounds.
- Claustrophobia or uncomfortable in small spaces.
- <70% on the Achenbach scale (either from Youth Self Report (YSR) or Adult Self Report (ASR)).
- IQ < 80 or IQ > 130.
- Pregnancy or lactation, lack of effective birth control during 15 days before the scans.
- Currently employed as radiation worker; or participation in radioactive drug research protocols within the previous year such that the total cumulative annual radiation dose (i.e., from participation in the previous radioactive drug study [studies] and this study) would exceed the radiation dose limits specified in the FDA regulations (i.e., 21 CFR 361.1) that govern the research use of [C-11]UCB-J
- History of drug or alcohol abuse (from parent study eligibility).
学习计划
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:PET Imaging Supplemental Component
Adult participants enrolled in the parent study, will be given the option to be a part of the PET imaging supplemental project.
Maximum enrollment is 60 adult participants.
Interested participants will be consented into the PET portion, and will have a single PET scan (as outlined in the Study Description section).
|
[11C]UCB-J (~ 15 mCi and ≤ 6μg) will be injected as a slow intravenous bolus.
Following an intravenous bolus injection of [11C]UCB-J, the participants will be positioned in the scanner for a low dose CT scan (for attenuation correction) fifty-five minutes after the [11C]UCB-J injection, and emission data will be collected.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Non-invasive quantification of synaptic pruning
大体时间:The PET-CT scan will be within approximately 30 days of the parent study MRI.
|
1. Age-related changes in synaptic density through young adulthood o Cross-sectional age-related (18-26 years of age) changes in synaptic density via SUVR quantified within the dorsolateral prefrontal cortex. |
The PET-CT scan will be within approximately 30 days of the parent study MRI.
|
|
Non-invasive quantification of synaptic pruning
大体时间:The PET-CT scan will be within approximately 30 days of the parent study MRI.
|
2. Within-subject associations of synapse density to MRI-derived measures of brain membrane byproducts o Synaptic density, based on SUVR modeling of [11C]UCB-J acquisitions, will be compared to ultra-high field (7 Tesla) [31P]MRSI measurement of membrane phospholipid levels obtained from the same participants. |
The PET-CT scan will be within approximately 30 days of the parent study MRI.
|
合作者和调查者
赞助
调查人员
- 首席研究员:Beatriz Luna, PhD、University of Pittsburgh
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他相关的 MeSH 术语
其他研究编号
- STUDY24060023
- 3R01MH067924-19S1 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.